These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24798885)

  • 21. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Camel milk inhibits inflammatory angiogenesis via downregulation of proangiogenic and proinflammatory cytokines in mice.
    Alhaider AA; Abdel Gader AG; Almeshaal N; Saraswati S
    APMIS; 2014 Jul; 122(7):599-607. PubMed ID: 24320686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine strain differences in inflammatory angiogenesis of internal wound in diabetes.
    Almeida SA; Orellano LA; Pereira LX; Viana CT; Campos PP; Andrade SP; Ferreira MA
    Biomed Pharmacother; 2017 Feb; 86():715-724. PubMed ID: 28063402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: the role of nitric oxide as a key mediator.
    Elesgaray R; Caniffi C; Savignano L; Romero M; Mac Laughlin M; Arranz C; Costa MA
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1385-94. PubMed ID: 22378819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1.
    Araújo FA; Rocha MA; Mendes JB; Andrade SP
    Biomed Pharmacother; 2010 Jan; 64(1):29-34. PubMed ID: 19811885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of the chemokine receptor CCR2 attenuates foreign body reaction to implants in mice.
    Castro PR; Marques SM; Viana CT; Campos PP; Ferreira MA; Barcelos LS; Andrade SP
    Microvasc Res; 2014 Sep; 95():37-45. PubMed ID: 25020267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice.
    Mendes JB; Rocha MA; Araújo FA; Moura SA; Ferreira MA; Andrade SP
    Microvasc Res; 2009 Dec; 78(3):265-71. PubMed ID: 19732781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ST2 deletion accelerates inflammatory-angiogenesis and remodeling in subcutaneous implants in mice.
    Viana CTR; Orellano LAA; Machado CT; Almeida CP; de Lazari MGT; Campos PP; Andrade SP
    Microvasc Res; 2022 Jan; 139():104277. PubMed ID: 34752815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R; Dai Y; Gao XH; Lu D; Xia YF
    Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternagin-C, a disintegrin-like protein from Bothrops alternatus venom, attenuates inflammation and angiogenesis and stimulates collagen deposition of sponge-induced fibrovascular tissue in mice.
    Rabelo LFG; Ferreira BA; Deconte SR; Tomiosso TC; Dos Santos PK; Andrade SP; Selistre de Araújo HS; Araújo FA
    Int J Biol Macromol; 2019 Nov; 140():653-660. PubMed ID: 31442506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural honey: a new and potent anti-angiogenic agent in the air-pouch model of inflammation.
    Eteraf-Oskouei T; Najafi M; Gharehbagheri A
    Drug Res (Stuttg); 2014 Oct; 64(10):530-6. PubMed ID: 24357137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers.
    Hu DE; Hiley CR; Smither RL; Gresham GA; Fan TP
    Lab Invest; 1995 May; 72(5):601-10. PubMed ID: 7538184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.